Memory problems and Mild Cognitive Impairment (MCI)

Clinics: Greater Manchester

Therapy Area: Mild Cognitive Impairment

Gender and Age: Males & Females aged 40 – 75

Reimbursement: £1,380 plus travel or transport.

About The Research...

The research team at MAC Clinical Research are conducting a study to test an existing medication to see if the treatment may help with cognition in people living with memory problems and Mild Cognitive Impairment (MCI) (for example, whether the medicine may improve remembering, thinking, attention and problem-solving).

What is MCI? Mild Cognitive Impairment (MCI) is a condition that causes minor problems with cognition – mental abilities such as memory or thinking. MCI causes cognitive changes that are serious enough to be noticed to the person affected and to family members and friends, but do not affect the individual’s ability to carry out everyday activities. Approximately 15% to 20% of people age 65 or older have MCI.

Medication repositioning (or repurposing) identifies new disease areas for an existing treatment that is already on the market.

Medication ‘repositioning’ has many advantages over traditional medicine discovery approaches. It can significantly reduce development time, and as compounds have demonstrated safety in people, it often avoids the need for large, expensive trials that can take many years to complete.

The study will run at our clinic in Manchester and will require 4 outpatient visits and 2 single night residential visits (overnight) over 9 weeks.

All eligible participants will receive the study medication during one of the two, 7-day treatment periods during the trial.

A full description of the study would be given to you before you decide to take part, both over the phone and during an appointment at the MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.

Reimbursement: £1,380 plus travel or transport.


* Key Inclusion Criteria:

  • Age 40-75
  • Diagnosis of MCI or a history of gradual subjective memory decline over the last year


* Key Exclusion Criteria:

  • Unable to attend study visits or comply with study restrictions


Other eligibility criteria will apply. Please contact MAC for more information.

Any other information

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.

Key Inclusion Criteria


Key Exclusion Criteria


If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • Hidden
  • (You can enter any supporting information here)
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Share on twitter
Share on whatsapp
Share on email